20-year Implant Survival in Periodontally Healthy and Compromised Patients

July 28, 2021 updated by: Mario Roccuzzo, University of Turin, Italy

Long-term (20-year) Implant Survival and Success Rates in Patients Healthy and Compromised Patients

The aim of this study will be to compare the long-term outcomes of sandblasted and acid-etched (SLA) implants in patients previously treated for periodontitis and in periodontally healthy patients (PHP) after a follow-up of at least 20-years.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

149

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Italy
      • Torino, Italy
        • Recruiting
        • University of Torino
        • Contact:
          • Mario Roccuzzo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients attending the principle investigator (M.R.), a specialist in periodontology, for dental implant therapy between December 1998 and September 2001 were screened for possible inclusion in the study.

Description

Inclusion Criteria:

  • complete edentulism;
  • presence of an implant-supported overdenture;
  • mucosal diseases;
  • alcohol and drug abuse;
  • pregnancy;
  • uncontrolled metabolic disorders;
  • aggressive periodontitis;
  • no interest in participating in the study

Exclusion Criteria:

  • Everything not as Inclusion Criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PHP
Other: Oral Rehabilitation with dental implants
Patients have been treated with oral dental implants supporting fixed dental prostheses
Moderate PCP
Other: Oral Rehabilitation with dental implants
Patients have been treated with oral dental implants supporting fixed dental prostheses
Severe PCP
Other: Oral Rehabilitation with dental implants
Patients have been treated with oral dental implants supporting fixed dental prostheses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Implant survival rate
Time Frame: Baseline; 10-year at the 20-year follow-up examination
Change in percentage of dental implants in situ / dental implants placed
Baseline; 10-year at the 20-year follow-up examination

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal Bone loss
Time Frame: Baseline; 10-year at the 20-year follow-up examination
Changes in mm of the peri-implant marginal bone loss
Baseline; 10-year at the 20-year follow-up examination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Turin, Italy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2021

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

July 1, 2023

Study Registration Dates

First Submitted

July 6, 2021

First Submitted That Met QC Criteria

July 28, 2021

First Posted (Actual)

July 30, 2021

Study Record Updates

Last Update Posted (Actual)

July 30, 2021

Last Update Submitted That Met QC Criteria

July 28, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 168/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bone Loss

Clinical Trials on Oral Rehabilitation with dental implants

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe